Ledipasvir is a direct-acting antiviral agent within the NS5A inhibitor class, primarily used in combination with other therapeutic agents to treat chronic hepatitis C virus infection. This category features… Read more
![Chemical structure of (S)-5-(tert-Butoxycarbonyl)-5-azaspiro[2.4]heptane-6-carboxylic Acid;](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1129634-44-1-S-5-tert-Butoxycarbonyl-5-azaspiro2.4heptane-6-carboxylic-Acid.png&w=3840&q=75)














![Chemical structure of Methyl ((R)-1-((S)-6-(5-(9,9-difluoro-7-(2-((1R,3S,4S)-2-((methoxycarbonyl)-L-valyl)-2-azabicyclo[2.2.1]heptan-3-yl)-1H-benzo[d]imidazol-6-yl)-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptan-5-yl)-3-methyl-1-oxobutan-2-yl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1256393-35-7-Methyl-R-1-S-6-5-99-difluoro-7-2-1R3S4S-2-methoxycarbonyl-L-valyl-2-azabicyclo2.2.1heptan-3-yl-1H-benzodimidazol-6-yl-9H-fluoren-2-yl-1H-.png&w=3840&q=75)
![Chemical structure of Methyl ((S)-1-((S)-6-(5-(7-(2-((1R,3S,4S)-2-((methoxycarbonyl)-L-valyl)-2-azabicyclo[2.2.1]heptan-3-yl)-1H-benzo[d]imidazol-6-yl)-9-oxo-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptan-5-yl)-3-methyl-1-oxobutan-2-yl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2040487-43-0-Methyl-S-1-S-6-5-7-2-1R3S4S-2-methoxycarbonyl-L-valyl-2-azabicyclo2.2.1heptan-3-yl-1H-benzodimidazol-6-yl-9-oxo-9H-fluoren-2-yl-1H-imidaz.png&w=3840&q=75)
![Chemical structure of Methyl ((S)-1-((S)-6-(5-(9,9-difluoro-7-(2-((1R,3S,4S)-2-((methoxycarbonyl)-D-valyl)-2-azabicyclo[2.2.1]heptan-3-yl)-1H-benzo[d]imidazol-6-yl)-9H-fluoren-2-yl)-1H-imidazol-2-yl)-5-azaspiro[2.4]heptan-5-yl)-3-methyl-1-oxobutan-2-yl)carbamate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1256391-66-8-Methyl-S-1-S-6-5-99-difluoro-7-2-1R3S4S-2-methoxycarbonyl-D-valyl-2-azabicyclo2.2.1heptan-3-yl-1H-benzodimidazol-6-yl-9H-fluoren-2-yl-1H-.png&w=3840&q=75)
![Chemical structure of tert-Butyl (1R,3R,4S)-3-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-1R3R4S-3-6-4455-Tetramethyl-132-dioxaborolan-2-yl-1H-benzodimidazol-2-yl-2-azabicyclo2.2.1heptane-2-carboxylate.png&w=3840&q=75)
![Chemical structure of tert-Butyl (1S,3S,4R)-3-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2Ftert-Butyl-1S3S4R-3-6-4455-Tetramethyl-132-dioxaborolan-2-yl-1H-benzodimidazol-2-yl-2-azabicyclo2.2.1heptane-2-carboxylate.png&w=3840&q=75)

Ledipasvir is a direct-acting antiviral agent within the NS5A inhibitor class, primarily used in combination with other therapeutic agents to treat chronic hepatitis C virus infection. This category features a comprehensive range of high-quality reference standards, including the active pharmaceutical ingredient, identified impurities, potential degradation products, diastereomers, and stable isotope labelled compounds. Pharmaceutical and analytical laboratories utilize these materials for impurity profiling, method validation, and rigorous quality control protocols during the drug development lifecycle. By incorporating these specific standards, researchers can accurately identify unknown substances, verify the consistency of their manufacturing processes, and ensure regulatory compliance in the analysis of this complex antiviral therapy.